UNSPSC 51351620: Estradiol benzoate

This classification denotes a therapeutic estradiol with the molecular formula C25H28O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1S4CJB5ZGN, chemically known as estra-1,3,5(10)-triene-3,17-diol (17.beta.)-, 3-benzoate but more generally known as estradiol benzoate, which bears US NIH Compound Identifier 3262. European Medicines Agency schedules Estradiol benzoate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07243MIG. The term ESTRADIOL BENZOATE is an International Non-Proprietary Name.

UNSPSC 51351620 Estradiol benzoate, a Commodity code, covers the procurement of this specific pharmaceutical compound — a synthetic estrogen used in veterinary and medical applications — by state and local health departments, animal control agencies, university research facilities, and correctional health services. State and local governments procure estradiol benzoate primarily for animal sterilization programs (particularly in public animal shelters and wildlife management), hormone replacement therapy in correctional facilities and public health clinics, and research applications at state universities and public health laboratories. The compound is typically sourced as an injectable formulation and may be purchased through standing orders, competitive bidding, or cooperative purchasing agreements with state pharmaceutical contracts.

The source contains no recent state or local contract opportunities tagged to this Commodity code. Without posted solicitations, issuing-body concentration, geographic spread, and representative recent activity cannot be characterized. Procurement under this code, if occurring, appears to operate through routine pharmaceutical supply contracts rather than discrete public notices, or activity has been minimal within the recent window the source covers.